SE460852B - T-cellinje dess framstaellning och anvaendning vid lymfokinframstaellning - Google Patents

T-cellinje dess framstaellning och anvaendning vid lymfokinframstaellning

Info

Publication number
SE460852B
SE460852B SE8203623A SE8203623A SE460852B SE 460852 B SE460852 B SE 460852B SE 8203623 A SE8203623 A SE 8203623A SE 8203623 A SE8203623 A SE 8203623A SE 460852 B SE460852 B SE 460852B
Authority
SE
Sweden
Prior art keywords
cells
cell line
human
hybrid
cell
Prior art date
Application number
SE8203623A
Other languages
English (en)
Swedish (sv)
Inventor
Tadamitsu Kishimoto
Yuichi Yamamura
Original Assignee
Tadamitsu Kishimoto
Yuichi Yamamura
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP56091265A external-priority patent/JPS57206383A/ja
Priority claimed from JP56122815A external-priority patent/JPS5823785A/ja
Application filed by Tadamitsu Kishimoto, Yuichi Yamamura filed Critical Tadamitsu Kishimoto
Publication of SE460852B publication Critical patent/SE460852B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
SE8203623A 1981-06-12 1982-06-10 T-cellinje dess framstaellning och anvaendning vid lymfokinframstaellning SE460852B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56091265A JPS57206383A (en) 1981-06-12 1981-06-12 Human t cellular line
JP56122815A JPS5823785A (ja) 1981-08-04 1981-08-04 ヒトｔ細胞ライン

Publications (1)

Publication Number Publication Date
SE460852B true SE460852B (sv) 1989-11-27

Family

ID=26432716

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8203623D SE8203623L (sv) 1981-06-12 1982-06-10 Humana t-celler
SE8203623A SE460852B (sv) 1981-06-12 1982-06-10 T-cellinje dess framstaellning och anvaendning vid lymfokinframstaellning

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE8203623D SE8203623L (sv) 1981-06-12 1982-06-10 Humana t-celler

Country Status (16)

Country Link
US (1) US4544632A (no)
AT (2) AT387235B (no)
AU (1) AU555913B2 (no)
CA (1) CA1189805A (no)
CH (1) CH663795A5 (no)
DE (2) DE3249567C2 (no)
DK (1) DK255882A (no)
ES (1) ES513027A0 (no)
FI (1) FI76118C (no)
FR (1) FR2507620A1 (no)
GB (1) GB2102832B (no)
IT (1) IT1164454B (no)
NL (1) NL8202379A (no)
NO (1) NO162669C (no)
NZ (1) NZ200849A (no)
SE (2) SE8203623L (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0096839B1 (en) * 1982-06-09 1989-01-25 Asahi Kasei Kogyo Kabushiki Kaisha Method for producing human antibody
NZ206699A (en) * 1982-12-30 1989-08-29 Bio Response Inc Process for the production of serum independent cell lines
JPS59169492A (ja) * 1983-03-15 1984-09-25 Asahi Chem Ind Co Ltd ヒト融合細胞からの生理活性物質の産生方法
JPS59169489A (ja) * 1983-03-15 1984-09-25 Otsuka Pharmaceut Co Ltd ヒト培養株化細胞
US4728614A (en) * 1983-05-18 1988-03-01 Ortho Pharmaceutical Mutant human T cell line producing immunosuppressive factor and method for obtaining such mutants
US4843004A (en) * 1984-05-11 1989-06-27 Sloan-Kettering Institute For Cancer Research Method for the production of human T-T cell hybrids and production suppressor factor by human T-T cell hybrids
US4665032A (en) * 1984-06-28 1987-05-12 Cornell Research Foundation, Inc. Human T cell hybridomas which produce immunosuppressive factors
ATE82588T1 (de) * 1986-04-28 1992-12-15 Endotronics Inc Zuchtverfahren fuer leukocyten.
NO162160C (no) * 1987-01-09 1989-11-15 Medi Cult As Serumfritt vekstmedium, samt anvendelse derav.
US5112735A (en) * 1987-06-22 1992-05-12 University Of Vermont Detection of lymphocyte amplification
US5482837A (en) * 1994-01-14 1996-01-09 University Of Vermont Methods of identifying lymphocytes with mutator phenotypes
US6113903A (en) * 1989-03-21 2000-09-05 The Immune Response Corporation Peptides and methods against diabetes
US5827642A (en) * 1994-08-31 1998-10-27 Fred Hutchinson Cancer Research Center Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
US6316257B1 (en) 1996-03-04 2001-11-13 Targeted Genetics Corporation Modified rapid expansion methods (“modified-REM”) for in vitro propagation of T lymphocytes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT292366B (de) * 1968-08-28 1971-08-25 Johann Sackl Schweinezuchtstall
WO1982001461A1 (en) * 1980-07-18 1982-05-13 Leland Stanford Junior Univ Human hybridomas,precursors and products
US4451570A (en) * 1981-03-26 1984-05-29 The Regents Of The University Of California Immunoglobulin-secreting human hybridomas from a cultured human lymphoblastoid cell line
US4401756A (en) * 1981-04-14 1983-08-30 Immunex Corporation Process for preparing human interleukin 2
US4407945A (en) * 1981-04-29 1983-10-04 Immunex Corporation Constitutive production of interleukin 2 by a T cell hybridoma
US4434230A (en) * 1981-08-12 1984-02-28 Research Corporation Human nonsecretory plasmacytoid cell line

Also Published As

Publication number Publication date
DE3222072C2 (de) 1986-08-14
FR2507620B1 (no) 1984-10-19
NO821949L (no) 1982-12-13
SE8203623L (sv) 1982-12-13
US4544632A (en) 1985-10-01
ES8305039A1 (es) 1983-04-01
DE3222072A1 (de) 1983-04-07
IT8205179A0 (it) 1982-06-10
GB2102832B (en) 1985-03-20
ES513027A0 (es) 1983-04-01
ATA281883A (de) 1984-08-15
AT387235B (de) 1988-12-27
FI76118C (fi) 1988-09-09
CH663795A5 (de) 1988-01-15
ATA230482A (de) 1988-05-15
NO162669B (no) 1989-10-23
AU8447482A (en) 1982-12-16
FI822103A0 (fi) 1982-06-11
DK255882A (da) 1982-12-13
NL8202379A (nl) 1983-01-03
FR2507620A1 (fr) 1982-12-17
NO162669C (no) 1990-01-31
NZ200849A (en) 1985-01-31
AT377415B (de) 1985-03-25
IT1164454B (it) 1987-04-08
CA1189805A (en) 1985-07-02
AU555913B2 (en) 1986-10-16
GB2102832A (en) 1983-02-09
DE3249567C2 (de) 1986-10-02
FI76118B (fi) 1988-05-31

Similar Documents

Publication Publication Date Title
Lake et al. Production and characterization of cytotoxic Thy‐1 antibody‐secreting hybrid cell lines Detection of T cell subsets
Drexler The leukemia-lymphoma cell line factsbook
Namba et al. Establishment of five human myeloma cell lines
SE460852B (sv) T-cellinje dess framstaellning och anvaendning vid lymfokinframstaellning
JPH02227096A (ja) 抗体およびその製法
Nilsson et al. Mast cells and basophils
Flomenberg et al. Interleukin 2-dependent natural killer (NK) cell lines from patients with primary T cell immunodeficiencies.
Dorshkind et al. Characterization of early B lymphocyte precursors present in long-term bone marrow cultures.
Hyman Cell-surface-antigen mutants of haematopoietic cells. Tools to study differentiation, biosynthesis and function.
Reimann et al. Differentiation from precursors in athymic nude mouse bone marrow of unusual spontaneously cytolytic cells showing anti-self-H-2 specificity and bearing T cell markers.
EP0123527B1 (en) Hla d typing assay
Liedgens et al. Highly efficient purification of the labile plant enzyme 5-aminolevulinate dehydratase (EC 4.2. 1.24) by means of monoclonal antibodies
US4618585A (en) Hybridoma cell lines producing monoclonal antibodies directed against cervical cancer cells
Keller et al. Interleukins 2 and 3 regulate the in vitro proliferation of two distinguishable populations of 20-alpha-hydroxysteroid dehydrogenase-positive cells.
Brooks NK cell cloning technology and characteristics of NK cell clones
Haas et al. Methods for the establishment of continously growing cytolytic T cell clones
EP0103081B1 (en) Method of growing cells in vitro
Buxbaum et al. Analysis of Thy-1 variants of murine lymphoma cells
Schrader et al. The use of T cell hybridomas in the biochemical and biological characterization of multiple regulatory factors produced by T cells
Fauser et al. Identification of B cells in multilineage hematopoietic colonies derived from cells of patients with lymphocytic lymphoma.
JPS62278979A (ja) 動物細胞の培養方法
Palacios Conditions for the establishment in vitro of interleukin 3-dependent murine B cell precursor lines
YAMAMOTO et al. Macrophage-like chemotactic hybridomas active for various chemotactic factors
JPH02138969A (ja) ヒトｔ交雑細胞ライン
NO162915B (no) Fremgangsmaate for fremstilling av en human-t-hybrid-cellelinje.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8203623-7